Target-trial emulation in VA EHRs constructed eight parallel new-user trials comparing GLP-1 RA initiators with SGLT-2 inhibitor initiators under two protocols: incident SUDs and SUD-related adverse outcomes.
Source link
GLP-1s Reduced Risk of Developing Substance Use Disorders – AJMC
